Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024
Invivyd (Nasdaq: IVVD) has scheduled a conference call for November 14, 2024, at 8:30 a.m. ET to discuss its third quarter 2024 financial results and provide business updates. The company, which focuses on protection from serious viral infectious diseases, previously released preliminary Q3 2024 results on October 29, 2024. The webcast will include a Q&A session for analysts, who are advised to join 15 minutes early. A replay will be available on the company's investor relations website approximately two hours after the call ends.
Invivyd (Nasdaq: IVVD) ha programmato una conferenza telefonica per il 14 novembre 2024, alle 8:30 ET per discutere i risultati finanziari del terzo trimestre 2024 e fornire aggiornamenti sull'attività. L'azienda, che si concentra sulla protezione contro gravi malattie infettive virali, ha precedentemente pubblicato risultati preliminari per il terzo trimestre 2024 il 29 ottobre 2024. Il webcast includerà una sessione di domande e risposte per gli analisti, che sono invitati a collegarsi 15 minuti prima. Una registrazione sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda circa due ore dopo la fine della chiamata.
Invivyd (Nasdaq: IVVD) ha programado una conferencia telefónica para el 14 de noviembre de 2024, a las 8:30 a.m. ET para discutir sus resultados financieros del tercer trimestre de 2024 y proporcionar actualizaciones sobre el negocio. La compañía, que se centra en la protección contra enfermedades infecciosas virales graves, había publicado previamente resultados preliminares del tercer trimestre de 2024 el 29 de octubre de 2024. La transmisión incluirá una sesión de preguntas y respuestas para analistas, a quienes se les recomienda unirse 15 minutos antes. Una grabación estará disponible en el sitio web de relaciones con inversores de la compañía aproximadamente dos horas después de que finalice la llamada.
Invivyd (Nasdaq: IVVD)는 2024년 11월 14일 오전 8시 30분 ET에 2024년 3분기 재무 결과에 대해 논의하고 사업 업데이트를 제공하는 컨퍼런스 콜을 예정하고 있습니다. 심각한 바이러스 감염 질환으로부터의 보호에 중점을 둔 이 회사는 2024년 10월 29일 2024년 3분기 preliminary 결과를 발표했습니다. 이 웹캐스트는 분석가를 위한 Q&A 세션을 포함하며, 분석가들은 15분 일찍 참석할 것을 권장합니다. 통화가 끝난 후 약 2시간 후에 회사의 투자자 관계 웹사이트에서 다시 볼 수 있는 녹화가 제공될 것입니다.
Invivyd (Nasdaq: IVVD) a programmé une conférence téléphonique pour le 14 novembre 2024 à 8h30 ET afin de discuter de ses résultats financiers du troisième trimestre 2024 et de fournir des mises à jour commerciales. La société, qui se concentre sur la protection contre les maladies infectieuses virales graves, avait précédemment publié des résultats préliminaires pour le troisième trimestre 2024 le 29 octobre 2024. Le webinaire inclura une session de questions-réponses pour les analystes, qui sont invités à se connecter 15 minutes à l'avance. Un enregistrement sera disponible sur le site web des relations avec les investisseurs de l'entreprise environ deux heures après la fin de l'appel.
Invivyd (Nasdaq: IVVD) hat eine Telefonkonferenz für den 14. November 2024 um 8:30 Uhr ET angesetzt, um die finanziellen Ergebnisse des dritten Quartals 2024 zu besprechen und Geschäftsupdates zu geben. Das Unternehmen, das sich auf den Schutz vor schweren viralen Infektionskrankheiten konzentriert, hatte zuvor am 29. Oktober 2024 vorläufige Ergebnisse für das dritte Quartal 2024 veröffentlicht. Der Webcast wird eine Frage- und Antwortsitzung für Analysten umfassen, die empfohlen wird, sich 15 Minuten früher einzuwählen. Eine Wiederholung wird etwa zwei Stunden nach dem Ende des Anrufs auf der Website der Investorenbeziehungen des Unternehmens verfügbar sein.
- None.
- None.
WALTHAM, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it will host a conference call on Thursday, November 14, 2024, at 8:30 a.m. ET to discuss its financial results for the third quarter ended September 30, 2024, and provide recent business highlights. Invivyd reported preliminary third quarter 2024 results via press release on October 29, 2024.
Listeners can register for the webcast via this link. Analysts wishing to participate in the question-and-answer session should use this link and are advised to join 15 minutes prior to the start time. A replay of the webcast will be available via the company’s investor relations website approximately two hours after the call’s conclusion.
About Invivyd
Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. The company’s proprietary INVYMAB™ platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to address evolving viral threats. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for its first mAb in a planned series of innovative antibody candidates. Visit https://invivyd.com/ to learn more.
Contacts:
Media Relations
(781) 208-1747
media@invivyd.com
Investor Relations
(781) 208-1747
investors@invivyd.com
FAQ
When is Invivyd (IVVD) hosting its Q3 2024 earnings call?
When did Invivyd (IVVD) release its preliminary Q3 2024 results?
How can investors access the replay of Invivyd's (IVVD) Q3 2024 earnings call?
